Department of Ophthalmology, William Harvey Hospital, East Kent Hospitals University NHS Foundation Trust, Ashford, United Kingdom; and.
OCL Vision, London, United Kingdom.
Retina. 2023 Oct 1;43(10):1750-1762. doi: 10.1097/IAE.0000000000003873.
The mean change in best-corrected visual acuity (BCVA), intraocular pressure, and endothelial cell counts after intraocular lens (IOL) implantation and the incidence rate of postoperative complications were estimated by systematic review and meta-analysis to assess the surgical and refractive outcomes of the sutureless scleral fixation Carlevale IOL.
A literature search was conducted using PubMed, Embase, and Scopus. The weighted mean difference (WMD) was used to present the mean change in BCVA, intraocular pressure, and endothelial cell count after IOL implantation, whereas a proportional meta-analysis was used to estimate the pooled incidence rate of postoperative complications.
In the meta-analysis of 13 studies involving 550 eyes, the pooled WMD of the mean change in BCVA showed a significant improvement in BCVA in patients who underwent Carlevale IOL implantation (WMD = 0.38, 95% confidence interval: 0.30-0.46, P < 0.001; heterogeneity [I 2 ] = 52.02%). The subgroup analyses indicated that the mean change in BCVA was not significantly higher according to the last follow-up visit, with no statistically significant subgroup effect ( P = 0.21) (WMD up to 6 months: 0.34, 95% confidence interval: 0.23-0.45, I 2 = 58.32%, WMD up to 24 months: 0.42, 95% confidence interval: 0.34-0.51, I 2 = 38.08%). In the meta-analysis of 16 studies involving 608 eyes, the pooled incidence rate of postoperative complications was equal to 0.22 (95% confidence interval: 0.13-0.32, I 2 = 84.87, P ≤ 0.001).
Carlevale IOL implantation represents a reliable method of restoring vision in eyes with missing capsular or zonular support.
通过系统评价和荟萃分析评估无缝线巩膜固定 Carlevale 人工晶状体(IOL)植入术后最佳矫正视力(BCVA)、眼压和内皮细胞计数的平均变化以及术后并发症的发生率,以评估该手术的手术和屈光效果。
使用 PubMed、Embase 和 Scopus 进行文献检索。使用加权均数差(WMD)表示 IOL 植入术后 BCVA、眼压和内皮细胞计数的平均变化,使用比例荟萃分析估计术后并发症的总发生率。
在纳入的 13 项研究、涉及 550 只眼的荟萃分析中,Carlevale IOL 植入组患者 BCVA 的平均变化的汇总 WMD 显示出明显的改善(WMD=0.38,95%置信区间:0.30-0.46,P<0.001;异质性[I 2 ]=52.02%)。亚组分析表明,根据最后一次随访,BCVA 的平均变化并没有显著更高,且无统计学意义的亚组效应(P=0.21)(截至 6 个月时的 WMD:0.34,95%置信区间:0.23-0.45,I 2 =58.32%;截至 24 个月时的 WMD:0.42,95%置信区间:0.34-0.51,I 2 =38.08%)。在纳入的 16 项研究、涉及 608 只眼的荟萃分析中,术后并发症的总发生率为 0.22(95%置信区间:0.13-0.32,I 2 =84.87,P≤0.001)。
Carlevale IOL 植入术为缺乏囊袋或悬韧带支持的眼提供了一种可靠的视力恢复方法。